Development and Validation of a Predictive Score for Three-Year Mortality in Acute Ischemic Stroke Patients

Ioana Cristina Bârsan1, Silvina Iluţ2, Nicoleta Tohănean2

  • 1Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Medicina (Kaunas, Lithuania)
|September 28, 2024
PubMed

Insights

Researchers developed a new score to predict three-year mortality in acute ischemic stroke (AIS) patients. Key predictors include age, NIHSS score, hemoglobin, resistin levels, and carotid plaques.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Biostatistics

Background:

  • Acute ischemic stroke (AIS) is a major cause of mortality and long-term disability.
  • Optimizing treatment strategies requires better prediction of long-term outcomes.
  • A validated predictive score for mortality in AIS patients is needed.

Purpose of the Study:

  • To develop and validate a predictive score for three-year mortality in AIS patients.
  • To identify demographic, clinical, laboratory, and imaging parameters associated with mortality.
  • To assess the predictive value of resistin and leptin levels.

Main Methods:

  • A cohort of 244 AIS patients was followed for three years.
  • Patients were divided into predictive (n=164) and validation (n=80) groups.
  • Demographic, clinical, laboratory (resistin, leptin), and imaging data were analyzed.

Main Results:

  • Advanced age, high NIHSS score, low hemoglobin, elevated resistin, and carotid plaques predicted mortality.
  • The developed predictive model was successfully validated.
  • Leptin levels did not significantly predict three-year mortality.

Conclusions:

  • A novel predictive score for three-year mortality in AIS patients was developed and validated.
  • Key independent predictors include advanced age, high NIHSS, low hemoglobin, elevated resistin, and carotid plaques.
  • This score can aid in optimizing AIS patient management.